NFKB1 and myeloid sarcoma: However, it is currently unclear whether TAK1 is also activated in the brains of MS patients, while it has been shown that TAK1 and downstream NF-κB and MAPK signaling pathways are activated in EAE mice (Shin et al., 2003).